Almasio PL - Search Results

1

Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects.

Calvaruso V, Mazza M, Almasio PL. Calvaruso V, et al. Among authors: almasio pl. Expert Opin Drug Saf. 2011 May;10(3):429-35. doi: 10.1517/14740338.2011.559161. Epub 2011 Feb 16. Expert Opin Drug Saf. 2011. PMID: 21323500 Review.

2

Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.

Di Marco V, Almasio P, Vaccaro A, Ferraro D, Parisi P, Cataldo MG, Di Stefano R, Craxì A. Di Marco V, et al. J Hepatol. 2000 Sep;33(3):456-62. doi: 10.1016/s0168-8278(00)80282-2. J Hepatol. 2000. PMID: 11020002 Clinical Trial.

3

Weight-based dosing: which impact on efficacy and safety of therapy?

Almasio PL. Almasio PL. Dig Liver Dis. 2004 Nov;36 Suppl 3:S349-53. doi: 10.1016/s1590-8658(04)80005-7. Dig Liver Dis. 2004. PMID: 15645666 Review.

4

Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.

Venezia G, Licata A, Di Marco V, Craxì A, Almasio PL. Venezia G, et al. Among authors: almasio pl. Dig Liver Dis. 2005 Nov;37(11):882-5. doi: 10.1016/j.dld.2005.06.010. Epub 2005 Sep 15. Dig Liver Dis. 2005. PMID: 16169301

5

Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial.

Alaimo G, Di Marco V, Ferraro D, Di Stefano R, Porrovecchio S, D'Angelo F, Calvaruso V, Craxì A, Almasio PL. Alaimo G, et al. Among authors: almasio pl. World J Gastroenterol. 2006 Nov 14;12(42):6861-4. doi: 10.3748/wjg.v12.i42.6861. World J Gastroenterol. 2006. PMID: 17106937 Free PMC article. Clinical Trial.

6

Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.

Di Marco V, Almasio PL, Ferraro D, Calvaruso V, Alaimo G, Peralta S, Di Stefano R, Craxì A. Di Marco V, et al. Among authors: almasio pl. J Hepatol. 2007 Oct;47(4):484-91. doi: 10.1016/j.jhep.2007.04.020. Epub 2007 Jun 27. J Hepatol. 2007. PMID: 17692985 Clinical Trial.

7

Pegylated interferon therapy in chronic hepatitis C: lights and shadows of an innovative treatment.

Almasio PL, Cottone C, D'Angelo F. Almasio PL, et al. Dig Liver Dis. 2007 Sep;39 Suppl 1:S88-95. doi: 10.1016/s1590-8658(07)80018-1. Dig Liver Dis. 2007. PMID: 17936232

8

Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.

Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Licata A, et al. Among authors: almasio pl. Dig Liver Dis. 2010 Feb;42(2):143-8. doi: 10.1016/j.dld.2009.06.009. Epub 2009 Jul 21. Dig Liver Dis. 2010. PMID: 19625223

9

Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition.

Di Marco V, Bronte F, Cabibi D, Calvaruso V, Alaimo G, Borsellino Z, Gagliardotto F, Almasio PL, Capra M, Craxì A. Di Marco V, et al. Among authors: almasio pl. Br J Haematol. 2010 Feb;148(3):476-9. doi: 10.1111/j.1365-2141.2009.07996.x. Epub 2009 Nov 23. Br J Haematol. 2010. PMID: 19930183 Free article.

10

The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C.

Abenavoli L, Mazza M, Almasio PL. Abenavoli L, et al. Among authors: almasio pl. Hepat Mon. 2011 Apr;11(4):240-6. Hepat Mon. 2011. PMID: 22087150 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters